| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |